Suggestions
Shawnnah Monterrey
Breaking ground and reaching new heights!
Shawnnah Monterrey, MBA, is the founder and CEO of BeanStock Ventures, a company specializing in healthcare product development and regulatory compliance within the medical device industry.13 With over 20 years of experience in medical and life science software product development, Shawnnah has established herself as a prominent figure in the field.12
Career Background
Shawnnah's career spans nearly two decades, during which she held technical leadership roles at notable companies such as Illumina, Covidien (Medtronic), Invetech (Danaher), and Carl Zeiss Meditec.2 Her expertise lies in developing strategies and leading complex global product development programs, with a focus on medical instruments, life science, diagnostics, and clinical applications.2
Education and Achievements
- Bachelor's degree in Computer Science from the University of California, San Diego1
- Executive MBA from San Diego State University12
- Received numerous awards and nominations since founding BeanStock Ventures2
BeanStock Ventures
Founded in 2018, BeanStock Ventures is an FDA-accredited third-party 510(k) review organization.12 The company offers services such as:
- Regulatory strategy services
- FDA third-party review
- FDA compliance training
- Technical templates
- IVD analysis software platform4
Under Shawnnah's leadership, BeanStock Ventures doubled in size in 2021 and has secured long-term partnerships with numerous Fortune 500 companies.2
Additional Roles and Contributions
- Member of Tech Coast Angels2
- Advisory Board Member of Fowler College of Business at San Diego State University2
- Member of the National Institute of Health (NIH) Commercialization Readiness Pilot Special Emphasis Review Panel2
- Mentor for various MedTech accelerators and startups4
- Angel investor4
- Recurring NIH SBIR grant reviewer4
Shawnnah Monterrey continues to be a driving force in the medical device and healthcare technology sector, leveraging her extensive experience to guide innovative products to market.5

